3 results
Approved WMOWill not start
To determine the minimal dose of protirelin that is effective and safe to normalize plasma thyroid hormone levels in patients with prolonged critical illness.
Approved WMOCompleted
The objective of this project is to assess the applicability of [18F]PK209 for in vivo imaging of the NMDA receptor.
Approved WMOCompleted
Primary: To assess the efficacy of GNX compared with PBO, as adjunctive therapy for the treatment of primary seizure types in children with genetically-confirmed PCDH19-related epilepsy during the 17-week double-blind (DB) phase. Secondary: • To…